A doctor wearing a hazmat suit pictured administering a vaccine for a patient in Depok, Indonesia. Photo: EPA
A doctor wearing a hazmat suit pictured administering a vaccine for a patient in Depok, Indonesia. Photo: EPA
Muhammad Zulfikar Rakhmat
Opinion

Opinion

Muhammad Zulfikar Rakhmat

Indonesia’s Sinovac coronavirus vaccine trial raises safety, affordability concerns

  • President Joko Widodo’s demand for a vaccine to be available within months has sparked fears the country is rushing ahead without proper precautions
  • There are also concerns over cost and availability should the trials prove successful and whether ordinary Indonesians are being used as ‘human guinea pigs’

A doctor wearing a hazmat suit pictured administering a vaccine for a patient in Depok, Indonesia. Photo: EPA
A doctor wearing a hazmat suit pictured administering a vaccine for a patient in Depok, Indonesia. Photo: EPA
READ FULL ARTICLE